Donald Trump’s return sparks uncertainty for US pharma and healthcare industries

His possible repeal or restructuring of the Affordable Care Act (ACA), coupled with plans to appoint anti-vaccine advocate Robert F Kennedy Jr. to a prominent healthcare role, raises concerns over public health funding, vaccine policies, and healthcare coverage, according to GlobalData
The post Donald Trump’s return sparks uncertainty for US pharma and healthcare industries appeared first on Express Healthcare.